Central serous retinopathy and macular degeneration both affect the retinas in your eyes, but one does not lead to the other. They share similar symptoms but have differing causes and risk factors.

Age is the most significant risk factor for macular degeneration. Being 50 or older increases your chance of developing age-related macular degeneration. Studies have shown that you have a slightly ...

Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...

A clinical trial is typically the first look at how an experimental drug works in humans. Character Biosciences is entering the clinic with a trove of company-generated human data already in hand.

Dry age-related macular degeneration (AMD) significantly affects patients' daily activities and quality of life, regardless of visual impairment.

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

Is there a link between age-related macular degeneration and Alzheimer's disease? Age-related macular degeneration, or AMD, is a common eye condition and also a leading cause of vision loss among ...